Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1435)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3390)
  2. Solid Tumor Oncology Division (3390)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (636)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (110)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (702)
  2. Journal of Thoracic Oncology (515)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (781)
  2. Elsevier Inc. (736)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3390)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Analysis of EGFR and KRAS mutations in high-grade neuroendocrine carcinomas of the lung
    Meeting Abstract

    Rekhtman, N.; He, M.; Lau, C.; Nafa, K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Rebiopsy of patients with "acquired resistance" to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Miller, V. A.; Riely, G. J.; Arcila, M. E.; Oxnard, G.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Ladanyi, M.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Using biomarkers to predict response to EGFR inhibitors
    Meeting Abstract

    Kris, M. G.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of induction and adjuvant bevacizumab with cisplatin and docetaxel in patients with locally advanced NSCLC
    Meeting Abstract

    Kris, M. G.; Price, K. A.; Rusch, V. W.; Zhao, B. S.; Schwartz, L. H.; Guo, P. Z.; Tan, Y. Q.; Subzwari, S.; Finley, D.; Rizvi, N. A.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)
    Meeting Abstract

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Prognostic implications of EGFR and KRAS gene mutations in resected lung adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Marks, J.; Zheng, J.; Shen, R.; Dycoco, J.; Park, B. J.; Riely, G. J.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Impact of EGFR and KRAS mutations on clinical outcomes in previously untreated patients with advanced NSCLC treated with gefitinib or erlotinib: Results of an online tumor registry of clinical trials
    Meeting Abstract

    Jackman, D. M.; Miller, V. A.; Cioffredi, L. A.; Yeap, B. Y.; Jänne, P. A.; Riely, G. J.; Ruiz, M. G.; Giaccone, G.; Sequist, L. V.; Johnson, B. E.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Insulin-like growth factor-1 receptor expression in thymic malignancies
    Meeting Abstract

    Girard, N.; Teruya-Feldstein, J.; Riely, G. J.; Pao, W.; Rusch, V. W.; Kris, M.; Zakowski, M. F.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save